Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
horizontal line  
Search: 
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_
Topic
Topic Home
  What Everyone
Should Know & Do
  About Antibiotic
Resistance
  Healthcare Providers
  Partners
  Program Planners
  Media
  Campaign Info
  News & Highlights
  Campaign Materials
  Related CDC Programs
  References & Resources
  First Time Visitor
  Glossary
  Site Map
 Información en Español
Infórmese: Automedicarse con antibióticos puede perjudar su salud
Contact Info
 

English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760
Email: cdcinfo@cdc.gov

International Travel
Phone:
1-887-394-8747

_
Get Smart: Know When Antibiotics Work

Adobe Acrobat PDF Print-friendly version of this academic detailing sheet (PDF 51 KB)

Acute Bacterial Rhinosinusitis:
Physician Information Sheet (Adults)

Principles of appropriate antibiotic use for acute rhinosinusitis apply to the diagnosis and treatment of acute maxillary and ethmoid rhinosinusitis in otherwise healthy adults.


Sinus inflammation is often viral and usually resolves without antibiotics.

Background

  • Respiratory viruses typically cause inflammation of the nasalmucosa and maxillary sinuses.
  • Most cases of acute rhinosinusitis are due to uncomplicated viral infections.

Diagnosis

  • Most rhinovirus colds last 7 to 11 days (J Clin Microbiol 1997; 35:2864; JAMA 1967; 202:158).
  • Bacterial rhinosinusitis may be present if symptoms have been present >7 days and there is localization to the maxillary sinus.

Signs/Symptoms of Acute Maxillary Sinusitis (BMJ 1995;311:233)

Present
(N=92)
Absent
(N=82)
Odds
Ratio
Fever
89%
79%
2.1
Unilateral maxillary pain
51%
38%
1.9
Maxillary toothache
66%
51%
1.9
Unilateral maxillary
sinus tenderness
49%
32%
2.5
  • Generalized facial pain or tenderness, postnasal drainage, headache, and cough do not increase the predictive value of maxillary sinus symptoms.
  • Patients may rarely present with severe symptoms of bacterial rhinosinusitis less than 7 days duration (acute focal sinusitis). Consider immediate referral to an otolaryngologist for evaluation and drainage.
  • Sinus radiography is not recommended for routine evaluation of acute, uncomplicated bacterial rhinosinusitis.
    • Opacification and air-fluid level have sensitivity of ~ 73% and specificity of 80% (J Clin Epidemiol 2000;53:852).
    • Mucosal abnormalities are common in patients with viral infections (J Allergy Clin Immunol 1998;102:403).

Treatment

  • Most patients with acute bacterial rhinosinusitis improve without antibiotic treatment.
    • About 81% of antibiotic treated patients and 66% of controls are improved at 10-14 days (absolute benefit of 15%).
  • Patients with mild symptoms should not receive antibiotics, but symptomatic treatment may be helpful.
    • Topical and oral decongestants may reduce nasal symptoms.
    • Most randomized trials of symptomatic therapies have been inconclusive. Patients with moderate or severe symptoms may benefit from antibiotics. Use a narrow spectrum agent that covers S. pneumoniae and H. influenzae.
    • Amoxicillin remains an appropriate choice for uncomplicated infections.
    • Consider second line agent if no improvement or worsening after 72 hours.

Tips to Reduce Antibiotic Use

  • Tell patients that antibiotic use increases the risk of an antibiotic resistant infection.
  • Identify and validate patient concerns.
  • Recommend specific
    symptomatic therapy.
  • Spend time answering questions and offer a contingency plan if symptoms worsen.
  • Provide patient education materials on antibiotic resistance.
  • REMEMBER: Effective communication is more important than an antibiotic for patient satisfaction.

Key Reference

Cooper RJ et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: Background. Annals of Internal Medicine 2001;134(6):509-17.
 
 
Date: April 6, 2006
Content source: National Center for Immunization and Respiratory Diseases / Division of Bacterial Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
 Safer, Healthier People  USAGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435